Principal investigators at URI should consider and explore the variety of opportunities for industry collaborations and sponsorship as well as foundation grants. Some examples are linked below
Please note, to protect confidential information and intellectual property, we strongly advise you to discuss only the published aspects of your research when discussing possible research collaborations with companies or foundations. While most submission portals will request non-confidential summaries of your research, some may not, and it is prudent for you to contact the Research Foundation, OSP, and possibly export control before submitting a proposal through a company portal. PLEASE DO NOT POST ENABLING WORK.
| Company | Program Name and Link |
| Department of Defense (DOD) | Lung Cancer Research Program
Career Development Award Multiple Sclerosis Research Program Exploration – Hypothesis Development Award Peer Reviewed Cancer Research Program Idea Award with Special Focus Tick-Borne Disease Research Program Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcements. The Program Announcements are available electronically for downloading from the Grants.gov website (http://www.grants.gov), the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml) and the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org). All CDMRP funding opportunities, both recently and previously released, are available on the CDMRP website (http://cdmrp.army.mil). Submission is a two-step process requiring both (1) pre-application submission through the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org/) and (2) application submission through Grants.gov (http://www.grants.gov/). Refer to the General Application Instructions, Section II.A. for registration and submission requirements for eBRAP and Grants.gov. |
| Environmental Protection Agency (EPA) | SBIR Opportunities |
| Epilepsy Foundation | New Therapy Commercialization Grants Program: Up to $350,000 over two years. Supports later-stage development of new, more effective therapies for epilepsy by accelerating the advancement of research from the laboratory to patient. New therapies may include but are not limited to medicines, biologics or devices. Preference given to proposals that already have a commercial partner engaged to assist with development, and proposals that have committed or matched funding from their sponsoring institution, commercial partner, or other third party source.
https://www.epilepsy.com/make-difference/research-and-new-therapies/innovation/epilepsy-therapy-project/new-therapy Due Date: 2/1/2018 |
| Johnson & Johnson | Partner with J & J |
| Sanofi | Collaborate-Innovate (Innovation Challenge) |
| Eli Lilly | Lilly Research Award Program Open Innovation Drug Discovery Program |
| Takeda | Independent Medical Education Grants |
| Abbvie | Submit Your Idea Areas of Interest Licensing |
| Amgen | Licensing Opportunities Areas of Interest |
| Advinus | Partnering/Co-Development (adenosine receptor for IBD, COPD, SCD) Partnering for Drug Discovery/Drug Development |
| Alkermes | Medical Education Grants |
| Allergan | Medical Education Grants |
| Almac Discovery | Partnering and Collaboration Pipeline |
| Amyris | Collaboration |
| Agenus | In/Out Licensing |
| Ariad | Grants & Donations |
| BASF | Innovation Award |
| Baxter Healthcare | Bioscience Grants Other Grants |
| Bayer | Bayer Foundations Thrombosis Research Award Bayer Foundations Scientific Awards |
| Genentech | Clinical Fellows |
| Genentech | Program: CGN Healthcare-Related Charitable Support Goal: Supports projects focused on patient education, services and advocacy in the areas of minority health, clinical trial recruitment, personalized medicine, early diagnosis/detection and caregivers. Amount: 5 awards up to $100,000 Deadline: Executive Summary due September 9, 2016 Details: http://advancement.georgetown.edu/cfr/?id=090616Genentech%20 |
| GSK | Discovery Partnerships with Academia |
| Daiichi Sankyo | Partnership |
| Debiopharm SA | In-Licensing and Portfolio Objectives |
| EMD Serono | Partnering |
| Roche | Areas of Interest Venture Fund |
| Gilead | U.S. Corporate Grants & Giving |
| Janssen R & D | Area of Focus |
| Kyowa Kirin | Licensing and Partnering |
| Merck | Areas of Interest and Partnerships |
| Takeda | Areas of Interest Partnership Contacts |
| Otsuka | Healthcare-Related Charitable Contributions Otsuka Grants Application Portal |
| Pfizer | Submission of Opportunities Areas of Interest World R&D Partnering |
| Novo Nordisk | Partnering |
| Teva | Teva Sponsored Studies |
| The Esther A. & Joseph Klingenstein Fund, Inc. | 2018 Klingenstein-Simons Fellowship Awards in the Neurosciences: $225,000 over 3 years. Supports highly promising, early-career investigators engaged in cutting-edge basic or clinical research that may lead to a better understanding of neurological and psychiatric disorders. At this critical juncture in an early-career investigator’s career, when funding can be a challenge, the fellowship promotes higher-risk, and potentially higher-reward, projects.
Studies in these areas are of particular interest: ELIGIBILITY: Due Date: 2/15/2018 |
| National Institutes of Health (NIH) | Loan Repayment Programs Deadline: Targeted for repayment of student loans of doctoral level, biomedical or behavioral scientists conducting research funded by non-profit institutions. |
| Congressionally Directed Medical Research Program (CDMRP) | Peer-Reviewed Alzheimer’s Research Program LOI due, Full Application due Detailed descriptions of the funding opportunity, evaluation criteria, and submission requirements can be found in the Program Announcement. The Program Announcement is available electronically for downloading from the Grants.gov website (http://www.grants.gov), the CDMRP website (http://cdmrp.army.mil/funding/prgdefault.shtml) and the electronic Biomedical Research Application Portal (eBRAP) (https://eBRAP.org). |
| Damon Runyon Cancer Research Award Foundation | Physician-Scientist Training Award Deadline: |
Disclaimer: Listing of these companies and initiatives does not imply endorsement of University of Rhode Island or its affiliates, nor did University of Rhode Island receive any special privileges in listing these opportunities.